Tumor ablation with irreversible electroporation

PLoS ONE

Volumn 2, Issue 11, 2007, Pages

  Al Sakere, Bassim ^a,b   André, Franck ^a,b   Bernat, Claire ^a,b   Connault, Elisabeth ^a,b   Opolon, Paule ^a,b   Davalos, Rafael V ^c   Rubinsky, Boris ^d,e,f   Mir, Lluis M ^a,b  

^a INSTITUT GUSTAVE ROUSSY   (France)

^b UNIVERSITÉ PARIS SACLAY   (France)

^c VIRGINIA POLYTECHNIC INSTITUTE AND STATE UNIVERSITY   (United States)

^d University of California at Berkeley   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

EOSIN; HEMATOXYLIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER TRANSPLANTATION; CELL DEATH; CELL MEMBRANE PERMEABILITY; CELL STRUCTURE; CLINICAL PROTOCOL; CONTROLLED STUDY; ELECTRIC FIELD; ELECTRODE; ELECTROPORATION; ELECTROSURGERY; HEATING; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; MATHEMATICAL MODEL; MINIMALLY INVASIVE SURGERY; MOUSE; NICK END LABELING; NONHUMAN; OUTCOME ASSESSMENT; PULSE GENERATOR; SKIN CANCER; TREATMENT OUTCOME; TUMOR REGRESSION; TUMOR VASCULARIZATION; ANIMAL; C57BL MOUSE; DNA DAMAGE; SARCOMA; TEMPERATURE; TUMOR CELL LINE;

MUS;

ANIMALS; CELL LINE, TUMOR; DNA DAMAGE; ELECTROPORATION; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; MICE; MICE, INBRED C57BL; SARCOMA, EXPERIMENTAL; TEMPERATURE;

EID: 42649137911     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0001135     Document Type: Article

References (44)

1. Onik G, Rubinsky B, Zemel R, Weaver L, Diamond D, et al. (1991) Ultrasound-guided hepatic cryosurgery in the treatment of metastatic colon carcinoma. Preliminary results. Cancer 67: 901-907.
2. Onik GM, Cohen JK, Reyes GD, Rubinsky B, Chang Z, et al. (1993) Transrectal ultrasound-guided percutaneous radical cryosurgical ablation of the prostate. Cancer 72: 1291-1299.
3. Mouraviev V, Polascik TJ (2006) Update on cryotherapy for prostate cancer in 2006. Carr Opin Urol 16: 152-156.
4. de Baere T, Rehim MA, Teriitheau C, Deschamps F, Lapeyre M, et al. (2006) Usefulness of guiding needles for radiofrequency ablative treatment of liver tumors. Cardiovasc Intervent Radiol 29: 650-654.
5. Martin RC (2006) Hepatic tumor ablation: cryo versus radiofrequency, which is better? Am Surg 72: 391-392.
6. Orlowski S, Mir LM (1993) Cell electropermeabilization: a new tool for biochemical and pharmacological studies. Biochim Biophys Acta 1154: 51-63.
7. Mir LM (200 1) Therapeutic perspectives of in vivo cell electropermeabilization. Bioelectrochemistry 53: 1-10.
8. Andre F, Mir LM (2004) DNA electrotransfer: its principles and an updated review of its therapeutic applications. Gene Ther 11 Suppl 1: S33-42.
9. Mir LM, Moller PH, Andre F, Gehl J (2005) Electric pulse-mediated gene delivery to various animal tissues. Adv Genet 54: 83-114.
10. Huang Y, Rubinsky B (1999) Micro-Electroporation: Improving the efficiency and understanding of electrical permeabilization of cells. Biomedical Microdevices 2: 145-150.
11. Davalos R, Huang Y, Rubinsky B (2000) Electroporation: Bio-electrochemical mass transfer at the nano scale. Microscale Thermophysical Engineering 4: 147-159.
12. Davalos RV, Mir LM, Rubinsky B (2005) Tissue ablation with irreversible electroporation. Ann Biomed Eng 33: 223-231.
13. Edd JF, Horowitz L, Davalos RV, Mir LM, Rubinsky B (2006) In vivo results of a new focal tissue ablation technique: irreversible electroporation. IEEE Trans Biomed Eng 53: 1409-1415.
14. Rubinsky B, Onik G, Mikus P (2007) Irreversible electroporation: a new ablation modality-clinical implications. Technol Cancer Res Treat 6: 37-48.
15. Mir LM, Orlowski S, Belehradek J Jr, Paoletti C (199 1) Electrochemotherapy potentiation of antitumour effect of bleomycin by local electric pulses. Eur J Cancer 27: 68-72.
16. Mir LM, Glass LF, Sersa G, Teissie J, Domenge C, et al. (1998) Effective treatment of cutaneous and subcutaneous malignant tumours by electrochemotherapy. Br J Cancer 77: 2336-2342.
17. Mir UYI, Gehl J, Sersa G, Collins CG, Garbay JR, et al. (2006) Standard Operating Procedures of the Electrochemotherapy. Eur J Cancer Supplements 4: 14-25.
18. Marty M, Sersa G, Garbay JR, Gehl J, Collins CG, et al. (2006) Electrochemotherapy - an easy, highly effective and safe treatment of cutaneous and subcutaneous metastases: results of the ESOPE (European Standard Operating Procedures of Electrochemotherapy) study. Eur J Cancer Supplements 4: 3-13.
19. Deng J, Schoenbach KH, Buescher ES, Hair PS, Fox PM, et al. (2003) The effects of intense submicrosecond electrical pulses on cells. Biophys J 84: 2709-2714.
20. Beebe SJ, White J, Blackmore PF, Deng Y, Somers K, et al. (2003) Diverse effects of nanosecond pulsed electric fields on cells and tissues. DNA Cell Biol 22: 785-796.
21. Gowrishankar TR, Weaver JC (2006) Electrical behavior and pore accumulation in a multicellular model for conventional and supra-electroporation. Biochem Biophys Res Commun 349: 643-653.
22. Belehradek M, Domenge C, Luboinski B, Orlowski S, Belehradek J Jr, et al. (1993) Electrochemotherapy, a new antitumor treatment. First clinical phase I-II trial. Cancer 72: 3694-3700.
23. Gothelf A, Mir LM, Gehl J (2003) Electrochemotherapy: results of cancer treatment using enhanced delivery of bleomycin by electroporation. Cancer Treat Rev 29: 371-387.
24. Sersa G, Cemazar M, Rudolf Z (2003) Electrochemotherapy: advantages and drawbacks in treatment of cancer patients. Cancer Therapy 1: 133-142.
25. Sersa G (2006) The State-of-the-art of electrochemotherapy before the ESOPE study; advantages and clinical uses. Eur J Cancer Supplements 4: 52-59.
26. Nuccitelli R, Pliquett U, Chen X, Ford W, James Swanson R, et al. (2006) Nanosecond pulsed electric fields cause melanomas to self-destruct. Biochem Biophys Res Commun 343: 351-360.
27. Belchradek J Jr, Barski G, Thonier M (1972) Evolution of cell-mediated antitumor immunity in mice bearing a syngeneic chemically induced tumor. Influence of tumor growth, surgical removal and treatment with irradiated tumor cells. Int J Cancer 9: 461-469.
28. United Kingdom Co-ordinating Committee on Cancer Research (UKCCCR) Guidelines for the Welfare of Animals in Experimental Neoplasia. (Second Edition). Br J Cancer 77: 1-10.
29. Becker SM, Kuznetsoz AV (2006) Numerical Modeling of In Vivo Plate Electroporation Thermal Dose Assessment. ASME J of Biomechanical Engineering 128: 76-84.
30. Damianou CA, Hynynen K, Fan X (1995) Evaluation of accuracy of a theoretical model for predicting die necrosed tissue volume during focused ultrasound surgery. IEEE Transactions on Ultrasonics, Ferroelectrics and Frequency Control 42: 182-187.
31. Sapareto S, Dewey W (1984) Thermal dose determination in cancer therapy. Int J radiation oncology Biol Phys 10: 787-800.
32. Davalos RV, Rubinsky B, Mir LM (2003) Theoretical analysis of the thermal effects during in vivo tissue electroporation. Bioelectrochemistry 61: 99-107.
33. Incropera FP, DeWitt DP (2002) Chapter 5: Transient Conduction. In: Incropera FP, DeWitt DP, eds (2002) Introduction to Heat Transfer. New York: John Wiley and Sons.
34. White FM (1988) Chapter 1: Introduction. Heat and Mass Transfer Addision-Wesley Publishing Company, Inc. pp 1-46.
35. Deng ZS, Liu J (2001) Blood perfusion-based model for characterizing the temperature fluctuations in living tissue. Phys A STAT Mech Appl 300: 521-530.
36. Swarup A, Stuchly SS, Surowiec A (1991) Dielectric properties of mouse MCAI fibrosarcoma at different stages of development. Bioelectromagnetics 12: 1-8.
37. White FM (1988) Appendix C: properties of Metallic Solids Heat and Mass Transfer Addision-Wesley Publishing Company, Inc. pp 672-673,
38. Al-Sakere B, Bernat C, André F, Connault E, Opolon P, Navalos RV, Mir LM (2007) A study of the immunological response to tumor ablation with irreversible electroporation. Technol Cancer Res Treat 6: 301-306.
39. Miklavcic D, Corovic S, Pucihar G, Pavselj N (2006) Importance of tumour coverage by sufficiently high local electric field for effective clectrochemotherapy. Eur J Cancer Supplements 4: 45-51.
40. Miklavcic D, Beravs K, Semrov D, Cemazar M, Dernsar F, et al. (1998) The importance of electric field distribution for effective in vivo electroporation of tissues. Biophys J 74: 2152-2158.
41. Miklavcic D, Semrov D, Mekid H, Mir LM (2000) A validated model of in vivo electric field distribution in tissues for electrochemotherapy and for DNA electrotransfer gene therapy. Biochim Biophys Acta 1523: 73-83.
42. Miller L, Leor J, Rubinsky B (2005) Cancer cells ablation with irreversible electroporation. Technol Cancer Res Treat 4: 699-765.
43. Hahn EW, Alfieri AA, Kim JH (1978) Single dose X-irradiation and concomitant hyperthermia on a murine fibrosarcoma. Cancer 42: 2591-2595.
44. Mohamed F, Stuart OA, Glehen O, Urano M, Sugarbaker PH (2004) Docetaxel and hyperthermia: factors that modify thermal enhancement. J Surg Oncol 88: 14-20.